Uihlein Richard E sold GALT
July 31, 2026 · Form 4 insider transaction
Uihlein Richard E sold an undisclosed number of shares of Galectin Therapeutics Inc. at $95475705.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Consists of $91,000,000 in principal and $14,475,705 in accrued interest.; The Line of Credit Convertible Notes are exercisable upon issuance when the issuer draws on the Line of Credit. Notes were issued on December 19, 2022; March 31, 2023; June 30, 2023; December 29, 2023; March 29, 2024; June 28, 2024; September30, 2024; April 30, 2025; June 30, 2025 and December 31, 2025. There was no expiration date; however, the maturity date of all Line of Credit Convertible Notes was June 30, 2027.